Marlena Schnieder1, Mohammed Chebbok2, Jan Liman3, Marco Robin Schroeter2, Michael Didié2, Frieder Wolf2, Mostafa Badr3, Ibrahim Allam3, Mathias Bähr3, Gerd Hasenfuß2. 1. Department for Cardiology & Pneumology/Heart Center, University Medical Center Göttingen, Robert-Koch Straße 40, 37075, Göttingen, Germany. marlena.schnieder@med.uni-goettingen.de. 2. Department for Neurology, University Medical Center Göttingen, Robert-Koch Straße 40, 37075, Göttingen, Germany. 3. Department for Cardiology & Pneumology/Heart Center, University Medical Center Göttingen, Robert-Koch Straße 40, 37075, Göttingen, Germany.
Abstract
BACKGROUND: Echocardiography is one of the main diagnostic tools for the diagnostic workup of stroke and is already well integrated into the clinical workup. However, the value of transthoracic vs. transesophageal echocardiography (TTE/TEE) in stroke patients is still a matter of debate. Aim of this study was to characterize relevant findings of TTE and TEE in the management of stroke patients and to correlate them with subsequent clinical decisions and therapies. METHODS: We evaluated n = 107 patients admitted with an ischemic stroke or transient ischemic attack to our stroke unit of our university medical center. They underwent TTE and TEE examination by different blinded investigators. RESULTS: Major cardiac risk factors were found in 8 of 98 (8.2%) patients and minor cardiac risk factors for stroke were found in 108 cases. We found a change in therapeutic regime after TTE or TEE in 22 (22.5%) cases, in 5 (5%) cases TEE leads to the change of therapeutic regime, in 4 (4%) TTE and in 13 cases (13.3%) TTE and TEE lead to the same change in therapeutic regime. The major therapy change was the indication to close a patent foramen ovale (PFO) in 9 (9.2%) patients with TTE and in 10 (10.2%) patients with TEE (p = 1.000). CONCLUSION: Major finding with clinical impact on therapy change is the detection of PFO. But for the detection of PFO, TTE is non inferior to TEE, implicating that TTE serves as a good screening tool for detection of PFO, especially in young age patients. TRIAL REGISTRATION: The trial was registered and approved prior to inclusion by our local ethics committee (1/3/17).
BACKGROUND: Echocardiography is one of the main diagnostic tools for the diagnostic workup of stroke and is already well integrated into the clinical workup. However, the value of transthoracic vs. transesophageal echocardiography (TTE/TEE) in strokepatients is still a matter of debate. Aim of this study was to characterize relevant findings of TTE and TEE in the management of strokepatients and to correlate them with subsequent clinical decisions and therapies. METHODS: We evaluated n = 107 patients admitted with an ischemic stroke or transient ischemic attack to our stroke unit of our university medical center. They underwent TTE and TEE examination by different blinded investigators. RESULTS: Major cardiac risk factors were found in 8 of 98 (8.2%) patients and minor cardiac risk factors for stroke were found in 108 cases. We found a change in therapeutic regime after TTE or TEE in 22 (22.5%) cases, in 5 (5%) cases TEE leads to the change of therapeutic regime, in 4 (4%) TTE and in 13 cases (13.3%) TTE and TEE lead to the same change in therapeutic regime. The major therapy change was the indication to close a patent foramen ovale (PFO) in 9 (9.2%) patients with TTE and in 10 (10.2%) patients with TEE (p = 1.000). CONCLUSION: Major finding with clinical impact on therapy change is the detection of PFO. But for the detection of PFO, TTE is non inferior to TEE, implicating that TTE serves as a good screening tool for detection of PFO, especially in young age patients. TRIAL REGISTRATION: The trial was registered and approved prior to inclusion by our local ethics committee (1/3/17).
Authors: Aristeidis H Katsanos; Theodora Psaltopoulou; Theodoros N Sergentanis; Alexandra Frogoudaki; Agathi-Rosa Vrettou; Ignatios Ikonomidis; Ioannis Paraskevaidis; John Parissis; Chrysa Bogiatzi; Christina Zompola; John Ellul; Nikolaos Triantafyllou; Konstantinos Voumvourakis; Athanassios P Kyritsis; Sotirios Giannopoulos; Anne W Alexandrov; Andrei V Alexandrov; Georgios Tsivgoulis Journal: Ann Neurol Date: 2016-03-11 Impact factor: 10.422
Authors: Scott E Kasner; Balakumar Swaminathan; Pablo Lavados; Mukul Sharma; Keith Muir; Roland Veltkamp; Sebastian F Ameriso; Matthias Endres; Helmi Lutsep; Steven R Messé; J David Spence; Krassen Nedeltechev; Kanjana Perera; Gustavo Santo; Veronica Olavarria; Arne Lindgren; Shrikant Bangdiwala; Ashkan Shoamanesh; Scott D Berkowitz; Hardi Mundl; Stuart J Connolly; Robert G Hart Journal: Lancet Neurol Date: 2018-09-28 Impact factor: 44.182
Authors: S Claiborne Johnston; J Donald Easton; Mary Farrant; William Barsan; Robin A Conwit; Jordan J Elm; Anthony S Kim; Anne S Lindblad; Yuko Y Palesch Journal: N Engl J Med Date: 2018-05-16 Impact factor: 91.245
Authors: Robert G Hart; Hans-Christoph Diener; Shelagh B Coutts; J Donald Easton; Christopher B Granger; Martin J O'Donnell; Ralph L Sacco; Stuart J Connolly Journal: Lancet Neurol Date: 2014-04 Impact factor: 44.182
Authors: Nicolas Feltgen; Jan Liman; Maximilian Schultheiss; Martin S Spitzer; Amelie Pielen; Sven Poli Journal: Ophthalmologe Date: 2021-08-04 Impact factor: 1.059